Topical metronidazol use in decubit ulcers
Keywords:
decubitus ulcer, metronidazole/therapeutics useAbstract
It was carried out a quasi-experimental study where 750 patients with ulcers for compression hemodynamically stable were selected, to which was applied treatment with sterile powdered metronidazol in the lesion. Therapeutic effectiveness of 99% was demonstrated.Downloads
References
1. Seok JI, Yi H, Song YM, Lee WY. Metronidazole surgical treatment of decubitus ulcers. Plast Recont Surg. 2002;20:206-10.
2. Lowe NJ. Use of topical metronidazole in moderate to severe rosacea. Adv Ther. 2003;20(4):177-90.
3. Jansson AK, Enblad P, Sjolin J. The surgical repair of decubitus ulcer in paraplegia: Further observation. Eur J Clin Microbiol Infect Dis. 2004;23(1):7-14.
4. Slik CJ, Martn GL, Sortor BV. Common intestinal parasites. Am Fam Physician. 2004;69(5):1161-8.
5. Mombelli A, Samaranayake LP. Topical and systemic antibiotics in the management of periodontal diseases. Int Dent J. 2004;54(1):3-14.
6. Swain BT, Ellis CN. Fibrin glue treatment of low rectal and pouch-anal anastomotic sinuses. Dis Colon Rectum. 2004;47(2):253-5.
7. Klebanoff MA, Hauth JC, MacPherson CA, Carey JC, Heine RP, Wapner RJ, et al. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol. 2004;190(2):362-70.
8. Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy. A systematic review. Ann Periodentol. 2003;8(1):115-81.
9. Hanes PJ, Purvis JP. Local anti-infective therapy: pharmacological agents. A systematic review. Ann Periodontol. 2003;8(1):79-98.
10. Chisholm SA, Owen RJ. Frameshift mutations in frxA occur frequently and do not provide a reliable marker for metronidazole resistance in UK isolates of helicobacter pylori. J Med Microbiol. 2004;53(2):135-40.
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).